As major media merger deals try to weave their way through regulatory clearance in the US, Sprint and T-Mobile are poised to become the next deal on the review block.
According to reports, Sprint parent company SoftBank and T-Mobile parent company Deutsche Telekom have struck an agreement on the basics of a merger in the US, a deal that would combine the nation’s third- and fourth-place wireless operators. The agreement would see SoftBank acquiring 50 percent of T-Mobile shares from Deutsche Telekom; Deutsche Telekom currently owns 67 percent of T-Mobile.
But, reports say, the German company remains unconvinced that the deal would pass regulatory clearance.
Both the Federal Communications Commission and the Department of Justice must approve of the merger. Authorities are also reviewing the proposed mergers between Comcast and Time Warner Cable, and AT&T and DirecTV.
All three deals are expected to face intense scrutiny. Deutsche Telekom has reportedly secured a $2 billion breakup fee should the merger between Sprint and T-Mobile fail.
But SoftBank has championed the combination, arguing that the deal is the only way to introduce a competitors strong enough to rival market leaders AT&T and Verizon.
Full content: Latin Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas